IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otani, A.
Right arrow Articles by Honda, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otani, A.
Right arrow Articles by Honda, Y.
(Investigative Ophthalmology and Visual Science. 2000;41:1192-1199.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Angiotensin II–Stimulated Vascular Endothelial Growth Factor Expression in Bovine Retinal Pericytes

Atsushi Otani1, Hitoshi Takagi1, Hideyasu Oh1, Kiyoshi Suzuma1, Miyo Matsumura1, Eiji Ikeda2 and Yoshihito Honda1

1 From the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; and the 2 Department of Pathology, Keio University School of Medicine, Tokyo, Japan.

PURPOSE. Angiotensin II (AII) has been shown to play a role in many vascular diseases. In the study described, the effect of AII on vascular endothelial growth factor (VEGF) expression and related intracellular signaling mechanism was investigated in bovine retinal microcapillary pericytes.

METHODS. Cultured bovine retinal microvascular endothelial cells and pericytes were prepared. VEGF expression was determined by Northern blot analysis and immunoprecipitation assay. Cell proliferation was assessed by DNA content growth assay. Reporter gene studies were performed to identify the AII responsible transcription-activating region of VEGF gene.

RESULTS. Angiotensin II induced a significant increase in VEGF mRNA in a time- and dose-dependent manner. Angiotensin II type I receptor antagonist inhibited this effect. Angiotensin II activates the transcription of VEGF gene without changing the mRNA half-life, and the AII responsible region was found in the 5'-flanking region of the VEGF gene. Angiotensin II also increased the expression of c–fos and c–jun mRNA, and antisense oligonucleotides against c-Fos blocked the AII–induced VEGF mRNA expression. The conditioned media of AII–stimulated pericyte cultures had a growth-promoting effect on endothelial cells, and this effect was inhibited almost completely by VEGF neutralizing antibody.

CONCLUSIONS. These findings suggest that AII might induce angiogenic activity through a paracrine function of VEGF in retinal microvascular cells.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Y. Khakoo, R. L. Sidman, R. Pasqualini, and W. Arap
Does the Renin-Angiotensin System Participate in Regulation of Human Vasculogenesis and Angiogenesis?
Cancer Res., November 15, 2008; 68(22): 9112 - 9115.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. I. Ager, J. Neo, and C. Christophi
The renin-angiotensin system and malignancy
Carcinogenesis, September 1, 2008; 29(9): 1675 - 1684.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield
Angiotensin II and Its Receptor Subtypes in the Human Retina
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3301 - 3311.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, H. Itoh, et al.
Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Nagai, K. Noda, T. Urano, Y. Kubota, H. Shinoda, T. Koto, K. Shinoda, M. Inoue, T. Shiomi, E. Ikeda, et al.
Selective Suppression of Pathologic, but Not Physiologic, Retinal Neovascularization by Blocking the Angiotensin II Type 1 Receptor
Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1078 - 1084.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Fujita, I. Hayashi, S. Yamashina, A. Fukamizu, M. Itoman, and M. Majima
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth
Carcinogenesis, February 1, 2005; 26(2): 271 - 279.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Zhang, M. Lassila, M. E. Cooper, and Z. Cao
Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors
Hypertension, February 1, 2004; 43(2): 276 - 281.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Watanabe, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, A. Hattori, M. Tsujimoto, and S. Mizutani
Adipocyte-Derived Leucine Aminopeptidase Suppresses Angiogenesis in Human Endometrial Carcinoma via Renin-Angiotensin System
Clin. Cancer Res., December 15, 2003; 9(17): 6497 - 6503.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Rizkalla, J. M. Forbes, M. E. Cooper, and Z. Cao
Increased Renal Vascular Endothelial Growth Factor and Angiopoietins by Angiotensin II Infusion Is Mediated by Both AT1 and AT2 Receptors
J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3061 - 3071.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-F. Jasmin, A. Calderone, T.-K. Leung, L. Villeneuve, and J. Dupuis
Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan
Cardiovasc Res, June 1, 2003; 58(3): 621 - 631.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. S. Wilson, B. G. Hobbs, W.-Y. Shen, T. P. Speed, U. Schmidt, C. G. Begley, and P. E. Rakoczy
Argon Laser Photocoagulation-Induced Modification of Gene Expression in the Retina
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1426 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. A. de Boer, Y. M. Pinto, A. J.H. Suurmeijer, S. Pokharel, E. Scholtens, M. Humler, J. M. Saavedra, F. Boomsma, W. H. van Gilst, and D. J. van Veldhuisen
Increased expression of cardiac angiotensin II type 1 (AT1) receptors decreases myocardial microvessel density after experimental myocardial infarction
Cardiovasc Res, February 1, 2003; 57(2): 434 - 442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. J. Moravski, S. L. Skinner, A. J. Stubbs, S. Sarlos, D. J. Kelly, M. E. Cooper, R. E. Gilbert, and J. L. Wilkinson-Berka
The Renin-Angiotensin System Influences Ocular Endothelial Cell Proliferation in Diabetes: Transgenic and Interventional Studies
Am. J. Pathol., January 1, 2003; 162(1): 151 - 160.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
F Mori, T Hikichi, T Nagaoka, J Takahashi, N Kitaya, and A Yoshida
Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats
Br. J. Ophthalmol., October 1, 2002; 86(10): 1172 - 1174.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Katada, M. Muramatsu, I. Hayashi, M. Tsutsumi, Y. Konishi, and M. Majima
Significance of Vascular Endothelial Cell Growth Factor Up-Regulation Mediated via a Chymase-Angiotensin-Dependent Pathway during Angiogenesis in Hamster Sponge Granulomas
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 949 - 956.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Sakurai, S. Alam, G. Pagan-Mercado, F. Hickman, J.-Y. Tsai, P. Zelenka, and S. Sato
Retinal Capillary Pericyte Proliferation and c-Fos mRNA Induction by Prostaglandin D2 through the cAMP Response Element
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2774 - 2781.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Ando, T. Nagasaka, M. Nomura, S.-I. Tsukahara, Y. Kotani, S. Toda, Y. Murata, A. Itakura, and S. Mizutani
Premenstrual Disappearance of Aminopeptidase A in Endometrial Stromal Cells around Endometrial Spiral Arteries/Arterioles during the Decidual Change
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2303 - 2309.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Nadal, G. M. Scicli, L. A. Carbini, and A. G. Scicli
Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H739 - H748.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Otani, H. Takagi, H. Oh, S. Koyama, and Y. Honda
Angiotensin II Induces Expression of the Tie2 Receptor Ligand, Angiopoietin-2, in Bovine Retinal Endothelial Cells
Diabetes, April 1, 2001; 50(4): 867 - 875.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology